Search Results - CA Prows
- Showing 1 - 2 results of 2
-
1
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for <i>CYP2D6</i> genotype and use of ondansetron and tropisetron by GC Bell, KE Caudle, Michelle Whirl‐Carrillo, RJ Gordon, Keiko Hikino, CA Prows, Andrea Gaedigk, José A. G. Agúndez, Senthilkumar Sadhasivam, Teri E. Klein, Matthias Schwab
Published 2016Artigo -
2
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network by William S. Bush, DR Crosslin, Aniwaa Owusu‐Obeng, John R. Wallace, Berta Almoguera, MA Basford, Suzette J. Bielinski, DS Carrell, John J. Connolly, Dana C. Crawford, KF Doheny, CJ Gallego, Allan Gordon, Brendan J. Keating, Jacqueline Kirby, Terrie Kitchner, Shannon Manzi, A R Mejia, Vivian Pan, Cassandra Perry, JF Peterson, CA Prows, James D. Ralston, Stuart A. Scott, Aaron Scrol, Maureen E. Smith, SC Stallings, Tamra L. Veldhuizen, W.A. Wolf, Simona Volpi, Kenneth L Wiley, Ruilin Li, Teri A. Manolio, Erwin P. Böttinger, MH Brilliant, David J. Carey, Rex L. Chisholm, CG Chute, Haines Jl, Hákon Hákonarson, JB Harley, Ingrid A. Holm, IJ Kullo, GP Jarvik, EB Larson, Catherine A. McCarty, MS Williams, Joshua C. Denny, LJ Rasmussen‐Torvik, DM Roden, MD Ritchie
Published 2016Artigo
Search Tools:
Related Subjects
Biology
Gene
Genetics
Genotype
Pharmacogenetics
Pharmacology
Antagonist
Astrophysics
Bioinformatics
CYP2D6
Computational biology
Copy-number variation
Cytochrome P450
Drug
Drug response
Genetic variation
Genome
Genomics
Guideline
Internal medicine
Medicine
Metabolism
Ondansetron
Pathology
Pharmacogenomics
Physics
Precision medicine
Receptor
Tropisetron
Variation (astronomy)